Your browser doesn't support javascript.
loading
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma.
Chang, Chun-Jung; Yang, Yao-Hsu; Chiu, Chiao-Juno; Lu, Li-Chun; Liao, Chien-Chia; Liang, Cher-Wei; Hsu, Chih-Hung; Cheng, Ann-Lii.
Afiliação
  • Chang CJ; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Yang YH; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
  • Chiu CJ; Graduate Institute of Immunology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Lu LC; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Liao CC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Liang CW; Graduate Institute of Immunology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Hsu CH; Graduate Institute of Pathology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Cheng AL; Division of Pathology, Fu Jen Catholic University Hospital, New Taipei City, Taiwan.
Int J Cancer ; 142(9): 1878-1889, 2018 05 01.
Article em En | MEDLINE | ID: mdl-29266245

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos Ly / Células Mieloides / Sorafenibe / Neoplasias Hepáticas Experimentais Limite: Animals Idioma: En Revista: Int J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos Ly / Células Mieloides / Sorafenibe / Neoplasias Hepáticas Experimentais Limite: Animals Idioma: En Revista: Int J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Taiwan